Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Lander

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
CNS Drug Reviews|December 14, 2002
Nicotinic cholinergic modulation: galantamine as a prototypeDiana S Woodruff-Pak, Cynthia Lander, Hugo Geerts
International Journal of Peptide Research and Therapeutics|October 10, 2017
Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic DysfunctionDavid I Brown, Brian C Cooley, Megan T Quintana, et al.
Journal of Molecular and Cellular Cardiology|September 27, 2014
MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibitionLei Xu, Cecelia C Yates, Pamela Lockyer, et al.
American Journal of Respiratory Cell and Molecular Biology|March 9, 2013
Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosisRagini Vittal, Amanda Fisher, Hongmei Gu, et al.
Journal of the American Heart Association|September 6, 2017
MMI-0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein CQinghang Meng, Bidur Bhandary, Hanna Osinska, et al.
Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
CNS Drug Reviews|December 14, 2002
Nicotinic cholinergic modulation: galantamine as a prototypeDiana S Woodruff-Pak, Cynthia Lander, Hugo Geerts
International Journal of Peptide Research and Therapeutics|October 10, 2017
Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic DysfunctionDavid I Brown, Brian C Cooley, Megan T Quintana, et al.
Journal of Molecular and Cellular Cardiology|September 27, 2014
MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibitionLei Xu, Cecelia C Yates, Pamela Lockyer, et al.
American Journal of Respiratory Cell and Molecular Biology|March 9, 2013
Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosisRagini Vittal, Amanda Fisher, Hongmei Gu, et al.
Journal of the American Heart Association|September 6, 2017
MMI-0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein CQinghang Meng, Bidur Bhandary, Hanna Osinska, et al.
Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.
Pageof 1